Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T75150 | GIP/GLP-1 dual receptor agonist-1 | ||
GIP/GLP-1 dual receptor agonist-1 (化合物 4) 是一种 GIP/GLP-1双受体激动剂。GIP/GLP-1 dual receptor agonist-1 可用于代谢紊乱和脂肪肝病,包括非酒精性脂肪性肝炎 (NASH)、非酒精性脂肪性肝病 (NAFLD) 的研究。 | |||
TP1111L |
Tirzepatide Acetate(2023788-19-2 free base)
|
Glucagon Receptor | GPCR/G Protein |
Tirzepatide Acetate(2023788-19-2 free base) 是一种双重 GIP / GLP-1 受体激动剂。 | |||
TP1111 |
Tirzepatide
LY-3298176 |
Glucagon Receptor | GPCR/G Protein |
Tirzepatide (LY-3298176) 是葡萄糖依赖性多肽 (GIP) 和胰高血糖素样肽-1 (GLP-1) 受体双重激动剂,具有神经保护活性,可改善血压并降低低密度脂蛋白 (LDL) 胆固醇和甘油三酯,可以用于研究糖尿病和肥胖症。 | |||
T37599 |
DA-JC4
DA-JC4 |
||
DA-JC4 is a compound with dual GLP-1/GIP receptor agonist properties. It is recommended for use in researching neurological diseases and investigating insulin signaling pathways[1][2][3]. | |||
TP1110 |
Tirzepatide hydrochloride
LY3298176 hydrochloride |
||
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. | |||
T76006 |
Tirzepatide TFA
Tirzepatide TFA(2023788-19-2 free base),LY3298176 TFA |
||
Tirzepatide TFA (LY3298176 TFA) 是葡萄糖依赖性胰岛素营养多肽(GIP)和胰高血糖素样肽-1(GLP-1)受体双重激动剂,有潜力用于 2 型糖尿病的研究。 | |||
T36760 | KQMEEEAVRLFIEWLKNGGPSSGAPPPS | ||
KQMEEEAVRLFIEWLKNGGPSSGAPPPS is a Exendin-4 peptide derivative. Exendin-4 is a pure GLP-1 receptor agonist. Exendin-4 peptide derivatives are structurally derived from Exendin-4 and may relates to dual GLP-1/glucagon receptor agonists. Their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake. These dual GLP-1/glucagon receptor agonists show reduced activity on the GIP receptor to reduce ... | |||
T82923 |
Bamadutide
SAR425899 |
||
Bamadutide (SAR425899)是一种高效的GLP-1/GIP受体激动剂,主要通过增强β细胞功能和降低葡萄糖吸收速率,从而改善餐后血糖控制。该化合物适用于2型糖尿病的研究。 |